SURI vs. OZEM ETF Comparison

Comparison of Simplify Exchange Traded Funds Simplify Propel Opportunities ETF (SURI) to Roundhill GLP-1 & Weight Loss ETF (OZEM)

SURI

Simplify Exchange Traded Funds Simplify Propel Opportunities ETF

SURI Description

The fund is an actively managed exchange-traded fund. The Sub-Adviser concentrates the fund's investments (i.e., invests more than 25% of its net assets) in the securities of issuers in the biotechnology, pharmaceuticals, healthcare technology, and life science tools and services industries. The Sub-Adviser employs an actively managed opportunistic multi-asset strategy that focuses on common stock, preferred stock, convertible bonds, structured notes, corporate notes and bonds, and ETFs that primarily invest in the preceding security types. The fund is non-diversified.

Grade (RS Rating)

Last Trade

$23.15

Average Daily Volume

5,497

Number of Holdings ^*

15

* may have additional holdings in another (foreign) market

OZEM

Roundhill GLP-1 & Weight Loss ETF

OZEM Description

OZEM targets the global weight management industry. The fund invests in companies involved in the development of GLP-1 and other weight loss drugs. GLP-1 agonists seek to aid in weight management by lowering blood sugar levels, reducing appetite, and promoting fullness. The portfolio consists of firms with GLP-1 and weight loss drugs that have been approved by or are currently undergoing Phase I, Phase II, and/or Phase III clinical trials of the US Food & Drug Administration (FDA), or any applicable food and drug regulator for non-US companies. The portfolio is constructed using a proprietary methodology, which selects companies with high levels of thematic relevance based on research of each companys public filings and disclosures. In addition, eligible securities must meet minimum market-cap and liquidity requirements. The actively managed fund, although rebalances portfolio weighting on at least a quarterly basis, may have a heavy concentration on a few names.

Grade (RS Rating)

Last Trade

$25.29

Average Daily Volume

37,622

Number of Holdings ^*

14

* may have additional holdings in another (foreign) market

Performance

Period	SURI	OZEM
30 Days	-1.79%	-10.60%
60 Days	-1.24%	-11.17%
90 Days	-0.03%	-12.25%
12 Months	41.29%

0 Overlapping Holdings

	Symbol	Grade	Weight in SURI	Weight in OZEM	Overlap

SURI Overweight 15 Positions Relative to OZEM

	Symbol	Grade	Weight
	APLT	C	24.2%
	PAGP	A	21.27%
	PHAT	F	8.7%
	AKRO	B	6.84%
	MDGL	B	5.87%
	RNA	C	5.13%
	ARDX	F	3.93%
	TSAT	D	1.83%
	SNDX	F	1.47%
	KYMR	D	1.37%
	KURA	F	1.3%
	ACHV	F	0.99%
	ATHA	D	0.62%
	CMPS	F	0.56%
	VRCA	F	0.27%

SURI Underweight 14 Positions Relative to OZEM

	Symbol	Grade	Weight
	NVO	F	-17.04%
	LLY	F	-14.13%
	ALT	C	-4.44%
	AZN	F	-3.99%
	VKTX	F	-3.39%
	AMGN	F	-3.26%
	PFE	F	-3.07%
	SRRK	C	-2.8%
	REGN	F	-2.4%
	RYTM	C	-2.3%
	TAK	D	-2.17%
	TERN	F	-1.97%
	CORT	B	-1.77%
	OPK	C	-1.72%

SURI: Top Represented Industries & Keywords

Industries: Biotechnology Communication Equipment Medical Care Facilities Oil & Gas Midstream

Keywords: Biopharmaceutical Cancer Medicine Biotechnology Medication Metabolic Disease Solid Tumors Benzamides Breast Cancer Clinical Medicine Clinical Trial Gastrointestinal Life Sciences Pharmaceutical Products Thyroid Treatment Of Breast Cancer Acid Acute Leukemia Alcohol Antineoplastic Drugs

OZEM: Top Represented Industries & Keywords

Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic

Keywords: Biopharmaceutical Obesity Pharmaceutical Products Cancer Inflammation Biotechnology Diabetes Medicine Neuroscience S&P 500 Alzheimer's Disease Anemia Asthma Cholesterol Depressive Disorder Hormones Hypertension Life Sciences Major Depressive Disorder Medication